Hesperitin Synergistically Promotes the Senescence Induction of Pentagamavunone-1 in Luminal Breast Cancer Cells, T47D

https://doi.org/10.22146/jtbb.88238

Fauziah Novita Putri Rifai(1), Mila Hanifa(2), Ummi Maryam Zulfin(3), Muthi Ikawati(4), Edy Meiyanto(5*)

(1) Master of Biotechnology Study Program, Graduate School, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia; Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
(2) Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
(3) Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
(4) Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia; Macromolecular Engineering Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
(5) Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada; Macromolecular Engineering Laboratory, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia
(*) Corresponding Author

Abstract


Pentagamavunone-1 (PGV-1), a curcumin analog, is a promising anticancer candidate for several cancers that have been proven in vitro and in vivo. However, the efficacy of PGV-1 against breast cancer is subject to improvement to achieve a more suitable application. Here we propose hesperitin, a citrus flavonoid, to increase the anticancer potency of PGV-1 in luminal breast cancer cells. We use the T47D cell as the model to investigate the effect of co-administration of PGV-1 and hesperitin on cell cycle block, apoptosis modulation, and senescence phenomena. PGV-1 and hesperitin showed strong and weak cytotoxicity with an IC50 value of 2 µM and 100 µM, respectively. The co-treatment of PGV-1 and hesperitin resulted in strong synergistic effects with combination index (CI) value of ≤ 0.2. This combination caused apoptosis in correlation with cell cycle disruption in G2/M phase at 48 h. In particular, PGV-1 and hesperitin combination increased the incidence of cellular senescence significantly higher than the single treatment. Despite its senescence potentiation, hesperitin did not induce senescence in normal cells. Taken together, hesperitin may increase the anticancer potency of PGV-1 by modulating cell cycle arrest and apoptosis via the senescence mechanism.

 


Keywords


Hesperitin; curcumin analog; synergistic effect; senescence; T47D cells.

Full Text:

PDF


References

Amalina, N.D. et al., 2023. In vitro synergistic effect of hesperidin and doxorubicin downregulates epithelial-mesenchymal transition in highly metastatic breast cancer cells. Journal of the Egyptian National Cancer Institute, 35(1), 6. doi: 10.1186/s43046-023-00166-3.

Baghban, R. et al., 2020. Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling, 18(1), 59. doi: 10.1186/s12964-020-0530-4.

Burstein, H.J., 2020. Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer. New England Journal of Medicine, 383(26), pp.2557–2570. doi: 10.1056/NEJMra1307118.

Čermák, V. et al., 2020. Microtubule-targeting agents and their impact on cancer treatment. European Journal of Cell Biology, 99(4), 151075. doi: 10.1016/j.ejcb.2020.151075.

Choi, S.S., Lee, S.H. & Lee, K.A., 2022. A Comparative Study of Hesperitin, Hesperidin and Hesperidin Glucoside: Antioxidant, Anti-Inflammatory, and Antibacterial Activities In Vitro. Antioxidants, 11(8), 1618. doi: 10.3390/antiox11081618.

Clusan, L. et al., 2023. A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer. International Journal of Molecular Sciences, 24(7), 6834. doi: 10.3390/ijms24076834.

Corrêa, T.A.F. et al., 2019. The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases. Frontiers in Nutrition, 6, 188. doi: 10.3389/fnut.2019.00188.

Crescenti, A. et al., 2022. Hesperidin Bioavailability Is Increased by the Presence of 2S-Diastereoisomer and Micronization—A Randomized, Crossover and Double-Blind Clinical Trial. Nutrients, 14(12), 2481. doi: 10.3390/nu14122481.

Endah, E. et al., 2022. Piperine Increases Pentagamavunon-1 Anti-cancer Activity on 4T1 Breast Cancer Through Mitotic Catastrophe Mechanism and Senescence with Sharing Targeting on Mitotic Regulatory Proteins. Iranian Journal of Pharmaceutical Research, 21(1), e123820. doi: 10.5812/ijpr.123820.

Fan, Y.J. & Zong, W.X., 2012. The cellular decision between apoptosis and autophagy. Chinese Journal of Cancer, 32(3), pp.121-129. doi: 10.5732/cjc.012.10106.

Filho, I.K. et al., 2021. Optimized Chitosan-Coated Gliadin Nanoparticles Improved the Hesperidin Cytotoxicity over Tumor Cells. Brazilian Archives of Biology and Technology, 64(spe), e21200795. doi: 10.1590/1678-4324-75years-2021200795

Hanahan, D. & Weinberg, R.A., 2011. Hallmarks of Cancer: The Next Generation. Cell, 144(5), pp.646–674. doi: 10.1016/j.cell.2011.02.013.

Hanifa, M. et al., 2022. Different Cytotoxic Effects of Vetiver Oil on Three Types of Cancer Cells, Mainly Targeting CNR2 on TNBC. Asian Pacific Journal of Cancer Prevention, 23(1), pp.241–251. doi: 10.31557/APJCP.2022.23.1.241.

Haque, A., Brazeau, D. & Amin, A.R., 2021. Perspectives on natural compounds in chemoprevention and treatment of cancer: An update with new promising compounds. European Journal of Cancer, 149, pp.165–183. doi: 10.1016/j.ejca.2021.03.009.

Hasbiyani, N.A.F. et al., 2021. Bioinformatics Analysis Confirms the Target Protein Underlying Mitotic Catastrophe of 4T1 Cells under Combinatorial Treatment of PGV-1 and Galangin. Scientia Pharmaceutica, 89(3), 38. doi: 10.3390/scipharm89030038.

Heery, A. et al., 2020. Precautions for Patients Taking Aromatase Inhibitors. Journal of the Advanced Practitioner in Oncology, 11(2), pp.184-189. doi: 10.6004/jadpro.2020.11.2.6.

Huang, W. et al., 2022. Cellular senescence: The good, the bad and the unknown. Nature Reviews Nephrology, 18(10), pp.611–627. doi: 10.1038/s41581-022-00601-z.

Ikawati, M. et al., 2023. The Synergistic Effect of Combination of Pentagamavunone-1 with Diosmin, Galangin, and Piperine in WiDr Colon Cancer Cells: In vitro and Target Protein Prediction. Journal of Tropical Biodiversity and Biotechnology, 8(2), 80975. doi: 10.22146/jtbb.80975.

Lee, H.J & Choi, C.H., 2022. Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4. BMC Cancer, 22(1), 446. doi: 10.1186/s12885-022-09446-y.

Lestari, B. et al., 2019. Pentagamavunon-1 (PGV-1) inhibits ROS metabolic enzymes and suppresses tumor cell growth by inducing M phase (prometaphase) arrest and cell senescence. Scientific Reports, 9(1), Article 1. doi: 10.1038/s41598-019-51244-3.

Lin, C.Y, Chen, Y.H. & Huang, Y.C., 2023. Hesperitin Induces Autophagy and Delayed Apoptosis by Modulating the AMPK/Akt/mTOR Pathway in Human Leukemia Cells In Vitro. Current Issues in Molecular Biology, 45(2), pp.1587–1600. doi: 10.3390/cimb45020102.

Madkour, L.H., 2020. Oxidative stress and oxidative damage-induced cell death. In Reactive Oxygen Species (ROS), Nanoparticles, and Endoplasmic Reticulum (ER) Stress-Induced Cell Death Mechanisms, pp.175–197. doi: 10.1016/B978-0-12-822481-6.00008-6.

Masoud, V. & Pagès, G., 2017. Targeted therapies in breast cancer: New challenges to fight against resistance. World Journal of Clinical Oncology, 8(2), 120. doi: 10.5306/wjco.v8.i2.120.

Meiyanto, E., Hermawan, A. & Anindyajati, A., 2012. Natural Products for Cancer-Targeted Therapy: Citrus Flavonoids as Potent Chemopreventive Agents. Asian Pacific Journal of Cancer Prevention, 13(2), pp.427–436. doi: 10.7314/APJCP.2012.13.2.427.

Meiyanto, E. & Larasati, Y.A., 2019. The Chemopreventive Activity of Indonesia Medicinal Plants Targeting on Hallmarks of Cancer. Advanced Pharmaceutical Bulletin, 9(2), pp.219–230. doi: 10.15171/apb.2019.025.

Meiyanto, E. et al., 2019. Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation. Advanced Pharmaceutical Bulletin, 9(3), pp.445–452. doi: 10.15171/apb.2019.053.

Meiyanto, E. et al., 2022. Bioinformatic and Molecular Interaction Studies Uncover That CCA-1.1 and PGV-1 Differentially Target Mitotic Regulatory Protein and Have a Synergistic Effect against Leukemia Cells. Indonesian Journal of Pharmacy, 33(2), pp.225-233. doi: 10.22146/ijp.3382.

Mueller, M. et al., 2018. Rhamnosidase activity of selected probiotics and their ability to hydrolyse flavonoid rhamnoglucosides. Bioprocess and Biosystems Engineering, 41(2), pp.221–228. doi: 10.1007/s00449-017-1860-5.

Musyayyadah, H. et al., 2021. The Growth Suppression Activity of Diosmin and PGV-1 Co-Treatment on 4T1 Breast Cancer Targets Mitotic Regulatory Proteins. Asian Pacific Journal of Cancer Prevention, 22(9), pp.2929–2938. doi: 10.31557/APJCP.2021.22.9.2929.

Novitasari, D. et al., 2021. CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention, 22(6), pp.1827–1836. doi: 10.31557/APJCP.2021.22.6.1827.

Nurhayati, A.P.D. et al., 2019. The phagocytosis activity of isoeugenol-ester compound on Mus musculus macrophage cell. Nusantara Bioscience, 11(2), Article 2. doi: 10.13057/nusbiosci/n110201.

Parhiz, H. et al., 2015. Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperitin: An Updated Review of their Molecular Mechanisms and Experimental Models: HESPERIDIN AND HESPERITIN AS ANTIOXIDANT AND ANTI-INFLAMMATORY AGENTS. Phytotherapy Research, 29(3), pp.323–331. doi: 10.1002/ptr.5256.

Putri, D.D.P. et al., 2022. Acute toxicity evaluation and immunomodulatory potential of hydrodynamic cavitation extract of citrus peels. Journal of Applied Pharmaceutical Science, 12(4), pp.136–145. doi: 10.7324/JAPS.2022.120415.

Salsabila, D. et al., 2023. Cytoprotective Properties of Citronella Oil (Cymbopogon nardus (L.) Rendl.) and Lemongrass Oil (Cymbopogon citratus (DC.) Stapf) through Attenuation of Senescent-Induced Chemotherapeutic Agent Doxorubicin on Vero and NIH-3T3 Cells. Asian Pacific Journal of Cancer Prevention, 24(5), pp.1667–1675. doi: https://doi.org/10.31557/APJCP.2023.24.5.1667.

Suski, J.M. et al., 2021. Targeting cell-cycle machinery in cancer. Cancer Cell, 39(6), pp.759–778. doi: 10.1016/j.ccell.2021.03.010.

Takumi, H. et al., 2012. Bioavailability of orally administered water-dispersible hesperitin and its effect on peripheral vasodilatation in human subjects: Implication of endothelial functions of plasma conjugated metabolites. Food & Function, 3(4), 389. doi: 10.1039/c2fo10224b.

Utomo, R.Y. et al., 2022. Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties. Advanced Pharmaceutical Bulletin, 12(3), pp.603–612. doi: 10.34172/apb.2022.063.

Wdowiak, K. et al., 2022. Bioavailability of Hesperidin and Its Aglycone Hesperitin—Compounds Found in Citrus Fruits as a Parameter Conditioning the Pro-Health Potential (Neuroprotective and Antidiabetic Activity)—Mini-Review. Nutrients, 14(13), 2647. doi: 10.3390/nu14132647.

Zulfin, U. et al., 2021. Reactive oxygen species and senescence modulatory effects of rice bran extract on 4T1 and NIH-3T3 cells co-treatment with doxorubicin. Asian Pacific Journal of Tropical Biomedicine, 11(4), 174. doi: 10.4103/2221-1691.310204.



DOI: https://doi.org/10.22146/jtbb.88238

Article Metrics

Abstract views : 315 | views : 246

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Journal of Tropical Biodiversity and Biotechnology

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Editoral address:

Faculty of Biology, UGM

Jl. Teknika Selatan, Sekip Utara, Yogyakarta, 55281, Indonesia

ISSN: 2540-9581 (online)